{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,11]],"date-time":"2026-06-11T11:16:17Z","timestamp":1781176577240,"version":"3.54.1"},"reference-count":44,"publisher":"Springer Science and Business Media LLC","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2024,6,6]]},"DOI":"10.7759\/cureus.61786","type":"journal-article","created":{"date-parts":[[2024,6,6]],"date-time":"2024-06-06T09:28:53Z","timestamp":1717666133000},"source":"Crossref","is-referenced-by-count":2,"title":["Esmolol\u2019s Role in Hemodynamic Management During Pheochromocytoma Surgery: A Comprehensive Review"],"prefix":"10.7759","author":[{"given":"Pavithra","family":"Konjety","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Vivek","family":"Chakole","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","reference":[{"key":"ref1","article-title":"Pheochromocytoma and paraganglioma","author":"Pacak K","year":"2000","unstructured":"Pacak K, Tella SH. Pheochromocytoma and paraganglioma. Feingold KR, Anawalt B, Blackman MR, et al. (ed): Endotext, South Dartmouth (MA); 2000."},{"key":"ref2","doi-asserted-by":"publisher","DOI":"10.4103\/0970-9185.161665","article-title":"Pheochromocytoma resection: current concepts in anesthetic management","volume":"31","author":"Ramakrishna H","year":"2015","unstructured":"Ramakrishna H. Pheochromocytoma resection: current concepts in anesthetic management. J Anaesthesiol Clin Pharmacol. 2015, 31:317-23. 10.4103\/0970-9185.161665","journal-title":"J Anaesthesiol Clin Pharmacol"},{"key":"ref3","doi-asserted-by":"publisher","DOI":"10.4103\/0970-1591.194781","article-title":"Current perioperative management of pheochromocytomas","volume":"33","author":"Ramachandran R","year":"2017","unstructured":"Ramachandran R, Rewari V. Current perioperative management of pheochromocytomas. Indian J Urol. 2017, 33:19-25. 10.4103\/0970-1591.194781","journal-title":"Indian J Urol"},{"key":"ref4","doi-asserted-by":"publisher","DOI":"10.1016\/j.bjae.2021.07.002","article-title":"Preoperative hypertension: perioperative implications and management","volume":"21","author":"Tait A","year":"2021","unstructured":"Tait A, Howell SJ. Preoperative hypertension: perioperative implications and management. BJA Educ. 2021, 21:426-32. 10.1016\/j.bjae.2021.07.002","journal-title":"BJA Educ"},{"key":"ref5","doi-asserted-by":"publisher","DOI":"10.4103\/TheIAForum.TheIAForum_32_23","article-title":"Perioperative hemodynamic management in surgery for phaeochromocytoma: a narrative review","volume":"24","author":"Krishna B","year":"2023","unstructured":"Krishna B, Khurana DK, Kohli S, Sharma KR, Gandhi R. Perioperative hemodynamic management in surgery for phaeochromocytoma: a narrative review. Indian anaesth forum. 2023, 24:11-20. 10.4103\/TheIAForum.TheIAForum_32_23","journal-title":"Indian anaesth forum"},{"key":"ref6","article-title":"Perioperative management of pheochromocytoma","author":"Kamath AS","year":"2024","unstructured":"Kamath AS, Singh K. Perioperative management of pheochromocytoma. StatPearls [Internet]. StatPearls Publishing, Treasure Island (FL); 2024. https:\/\/www.ncbi.nlm.nih.gov\/books\/NBK589634\/:"},{"key":"ref7","doi-asserted-by":"publisher","DOI":"10.21037\/gs.2019.10.20","article-title":"Surgical approach to patients with pheochromocytoma","volume":"9","author":"Patel D","year":"2020","unstructured":"Patel D. Surgical approach to patients with pheochromocytoma. Gland Surg. 2020, 9:322-42. 10.21037\/gs.2019.10.20","journal-title":"Gland Surg"},{"key":"ref8","doi-asserted-by":"publisher","DOI":"10.3390\/cancers11070936","article-title":"Postoperative management in patients with pheochromocytoma and paraganglioma","volume":"11","author":"Mamilla D","year":"2019","unstructured":"Mamilla D, Araque KA, Brofferio A, Gonzales MK, Sullivan JN, Nilubol N, Pacak K. Postoperative management in patients with pheochromocytoma and paraganglioma. Cancers (Basel). 2019, 11:936. 10.3390\/cancers11070936","journal-title":"Cancers (Basel)"},{"key":"ref9","doi-asserted-by":"publisher","DOI":"10.1002\/j.1552-4604.1986.tb02985.x","article-title":"Pharmacology and pharmacokinetics of esmolol","volume":"26","author":"Reynolds RD","year":"1986","unstructured":"Reynolds RD, Gorczynski RJ, Quon CY. Pharmacology and pharmacokinetics of esmolol. J Clin Pharmacol. 1986, 26:A3-A14. 10.1002\/j.1552-4604.1986.tb02985.x","journal-title":"J Clin Pharmacol"},{"key":"ref10","article-title":"Esmolol","author":"Pevtsov A","year":"2024","unstructured":"Pevtsov A, Kerndt CC, Ahmed I, Patel P, Fredlund KL. Esmolol. StatPearls [Internet]. StatPearls Publishing, Treasure Island (FL); 2024. https:\/\/www.ncbi.nlm.nih.gov\/books\/NBK518965\/:"},{"key":"ref11","doi-asserted-by":"publisher","DOI":"10.1210\/jc.2007-1720","article-title":"Preoperative management of the pheochromocytoma patient","volume":"92","author":"Pacak K","year":"2007","unstructured":"Pacak K. Preoperative management of the pheochromocytoma patient. J Clin Endocrinol Metab. 2007, 92:4069-79. 10.1210\/jc.2007-1720","journal-title":"J Clin Endocrinol Metab"},{"key":"ref12","doi-asserted-by":"publisher","DOI":"10.1038\/jhh.2008.172","article-title":"Preparation for surgery of phaeochromocytoma by blockade of alpha-adrenergic receptors with urapidil: what dose?","volume":"23","author":"Gosse P","year":"2009","unstructured":"Gosse P, Tauzin-Fin P, Sesay MB, Sautereau A, Ballanger P. Preparation for surgery of phaeochromocytoma by blockade of alpha-adrenergic receptors with urapidil: what dose?. J Hum Hypertens. 2009, 23:605-9. 10.1038\/jhh.2008.172","journal-title":"J Hum Hypertens"},{"key":"ref13","unstructured":"Esmolol injection. package insert. (2023). Accessed: May 26, 2024: https:\/\/www.drugs.com\/pro\/esmolol-injection.html."},{"key":"ref14","doi-asserted-by":"publisher","DOI":"10.1186\/s13054-020-03445-w","article-title":"Hemodynamic and anti-inflammatory effects of early esmolol use in hyperkinetic septic shock: a pilot study","volume":"25","author":"Levy B","year":"2021","unstructured":"Levy B, Fritz C, Piona C, et al.. Hemodynamic and anti-inflammatory effects of early esmolol use in hyperkinetic septic shock: a pilot study. Crit Care. 2021, 25:21. 10.1186\/s13054-020-03445-w","journal-title":"Crit Care"},{"key":"ref15","unstructured":"Esmolol (intravenous route) . (2023). Accessed. May 26, 2024: https:\/\/www.mayoclinic.org\/drugs-supplements\/esmolol-intravenous-route\/side-effects\/drg-20071133."},{"key":"ref16","doi-asserted-by":"publisher","DOI":"10.1097\/MD.0000000000029820","article-title":"Benefits of esmolol in adults with sepsis and septic shock: an updated meta-analysis of randomized controlled trials","volume":"101","author":"Zhang J","year":"2022","unstructured":"Zhang J, Chen C, Liu Y, Yang Y, Yang X, Yang J. Benefits of esmolol in adults with sepsis and septic shock: an updated meta-analysis of randomized controlled trials. Medicine (Baltimore). 2022, 101:e29820. 10.1097\/MD.0000000000029820","journal-title":"Medicine (Baltimore)"},{"key":"ref17","unstructured":"Esmolol. (2023). Accessed. May 26, 2024: https:\/\/www.apollopharmacy.in\/salt\/ESMOLOL."},{"key":"ref18","unstructured":"Beta blockers. (2023). Accessed. May 26, 2024: https:\/\/www.mayoclinic.org\/diseases-conditions\/high-blood-pressure\/in-depth\/beta-blockers\/art-20044522."},{"key":"ref19","article-title":"Alpha-Blockers","author":"Nachawati D","year":"2024","unstructured":"Nachawati D, Patel JB. Alpha-Blockers. StatPearls [Internet]. StatPearls Publishing, Treasure Island (FL); 2024. https:\/\/www.ncbi.nlm.nih.gov\/books\/NBK556066\/:"},{"key":"ref20","doi-asserted-by":"publisher","DOI":"10.1016\/s0895-7061(97)00161-1","article-title":"Impact of alpha- versus beta-blockers on hypertensive target organ damage: results of a double-blind, randomized, controlled clinical trial","volume":"10","author":"Schmieder RE","year":"1997","unstructured":"Schmieder RE, Langenfeld MR, Gatzka CD, Weidinger G, Schobel HP. Impact of alpha- versus beta-blockers on hypertensive target organ damage: results of a double-blind, randomized, controlled clinical trial. Am J Hypertens. 1997, 10:985-91. 10.1016\/s0895-7061(97)00161-1","journal-title":"Am J Hypertens"},{"key":"ref21","unstructured":"Beta blockers. (2023). Accessed. May 26, 2024: https:\/\/www.mayoclinic.org\/diseases-conditions\/high-blood-pressure\/in-depth\/beta-blockers\/art-20044522."},{"key":"ref22","doi-asserted-by":"publisher","DOI":"10.3389\/fphar.2021.682232","article-title":"The efficacy and safety of esmolol for septic shock: a systematic review and meta-analysis of randomized controlled trials","volume":"12","author":"Huang P","year":"2021","unstructured":"Huang P, Zheng X, Liu Z, Fang X. The efficacy and safety of esmolol for septic shock: a systematic review and meta-analysis of randomized controlled trials. Front Pharmacol. 2021, 12:682232. 10.3389\/fphar.2021.682232","journal-title":"Front Pharmacol"},{"key":"ref23","doi-asserted-by":"publisher","DOI":"10.1213\/ANE.0b013e3182025af7","article-title":"The safety of perioperative esmolol: a systematic review and meta-analysis of randomized controlled trials","volume":"112","author":"Yu SK","year":"2011","unstructured":"Yu SK, Tait G, Karkouti K, Wijeysundera D, McCluskey S, Beattie WS. The safety of perioperative esmolol: a systematic review and meta-analysis of randomized controlled trials. Anesth Analg. 2011, 112:267-81. 10.1213\/ANE.0b013e3182025af7","journal-title":"Anesth Analg"},{"key":"ref24","doi-asserted-by":"publisher","DOI":"10.2344\/anpr-65-03-17","article-title":"Anesthetic management of the hypertensive patient: Part II","volume":"65","author":"Yancey R","year":"2018","unstructured":"Yancey R. Anesthetic management of the hypertensive patient: Part II. Anesth Prog. 2018, 65:206-13. 10.2344\/anpr-65-03-17","journal-title":"Anesth Prog"},{"key":"ref25","doi-asserted-by":"publisher","DOI":"10.1530\/EDM-20-0101","article-title":"Perioperative control of paroxysmal hypertension using esmolol with alpha-blockade in a child with a germline mutated paraganglioma","volume":"2021","author":"Babiker A","year":"2021","unstructured":"Babiker A, Al Hamdan W, Kinani S, et al.. Perioperative control of paroxysmal hypertension using esmolol with alpha-blockade in a child with a germline mutated paraganglioma. Endocrinol Diabetes Metab Case Rep. 2021, 2021:10.1530\/EDM-20-0101","journal-title":"Endocrinol Diabetes Metab Case Rep"},{"key":"ref26","doi-asserted-by":"publisher","DOI":"10.5554\/22562087.e958","article-title":"Perioperative management of pheocromocytoma\/ paraganglioma: a comprehensive review","volume":"49","author":"Rom\u00e1n-Gonz\u00e1lez A","year":"2021","unstructured":"Rom\u00e1n-Gonz\u00e1lez A, Padilla-Zambrano H, Jimenez LFV. Perioperative management of pheocromocytoma\/ paraganglioma: a comprehensive review. Colomb J Anesthesiol. 2021, 49:3389. 10.5554\/22562087.e958","journal-title":"Colomb J Anesthesiol"},{"key":"ref27","unstructured":"Esmolol hydrochloride 10 mg\/ml solution for injection. (2023). Accessed. May 26, 2024: https:\/\/www.medicines.org.uk\/emc\/product\/3057\/smpc."},{"key":"ref28","doi-asserted-by":"publisher","DOI":"10.1016\/0735-1097(94)90411-1","article-title":"A new dosing regimen for esmolol to treat supraventricular tachyarrhythmia in Chinese patients","volume":"23","author":"Ko WJ","year":"1994","unstructured":"Ko WJ, Chu SH. A new dosing regimen for esmolol to treat supraventricular tachyarrhythmia in Chinese patients. J Am Coll Cardiol. 1994, 23:302-6. 10.1016\/0735-1097(94)90411-1","journal-title":"J Am Coll Cardiol"},{"key":"ref29","doi-asserted-by":"publisher","DOI":"10.5863\/1551-6776-19.4.302","article-title":"Optimizing pediatric esmolol dosing using computerized practitioner order entry","volume":"19","author":"Chao T","year":"2014","unstructured":"Chao T, Perry JC, Romanowski GL, Tremoulet AH, Capparelli EV. Optimizing pediatric esmolol dosing using computerized practitioner order entry. J Pediatr Pharmacol Ther. 2014, 19:302-9. 10.5863\/1551-6776-19.4.302","journal-title":"J Pediatr Pharmacol Ther"},{"key":"ref30","unstructured":"Esmolol dosage. (2023). Accessed. May 26, 2024: https:\/\/www.drugs.com\/dosage\/esmolol.html."},{"key":"ref31","doi-asserted-by":"publisher","DOI":"10.2196\/27765","article-title":"Validation of heart rate extracted from wrist-based photoplethysmography in the perioperative setting: prospective observational study","volume":"5","author":"Mestrom E","year":"2021","unstructured":"Mestrom E, Deneer R, Bonomi AG, et al.. Validation of heart rate extracted from wrist-based photoplethysmography in the perioperative setting: prospective observational study. JMIR Cardio. 2021, 5:e27765. 10.2196\/27765","journal-title":"JMIR Cardio"},{"key":"ref32","article-title":"Dose calculation","author":"Gage CB","year":"2024","unstructured":"Gage CB, Preuss CV. Dose calculation. StatPearls [Internet]. StatPearls Publishing, Treasure Island (FL); 2024. https:\/\/www.ncbi.nlm.nih.gov\/books\/NBK430836\/:"},{"key":"ref33","doi-asserted-by":"publisher","DOI":"10.1186\/1757-7241-20-15","article-title":"Early and individualized goal-directed therapy for trauma-induced coagulopathy","volume":"20","author":"Sch\u00f6chl H","year":"2012","unstructured":"Sch\u00f6chl H, Maegele M, Solomon C, G\u00f6rlinger K, Voelckel W. Early and individualized goal-directed therapy for trauma-induced coagulopathy. Scand J Trauma Resusc Emerg Med. 2012, 20:15. 10.1186\/1757-7241-20-15","journal-title":"Scand J Trauma Resusc Emerg Med"},{"key":"ref34","doi-asserted-by":"publisher","DOI":"10.4097\/kjae.2000.38.3.450","article-title":"A comparison of the effects on inducing hypotension and bradycardia between esmolol infusion alone and concomitant use of neostigmine for midcab anesthesia","volume":"38","author":"Sim WS","year":"2000","unstructured":"Sim WS, Ham BM, Moon HS. A comparison of the effects on inducing hypotension and bradycardia between esmolol infusion alone and concomitant use of neostigmine for midcab anesthesia. Korean J Anesthesiol. 2000, 38:450-6. 10.4097\/kjae.2000.38.3.450","journal-title":"Korean J Anesthesiol"},{"key":"ref35","unstructured":"Hypoglycemia (low blood sugar). (2021). Accessed. May 26, 2024: https:\/\/www.hopkinsmedicine.org\/health\/conditions-and-diseases\/diabetes\/hypoglycemia-low-blood-sugar."},{"key":"ref36","doi-asserted-by":"publisher","DOI":"10.4239\/wjd.v6.i7.912","article-title":"Mechanisms of hypoglycemia unawareness and implications in diabetic patients","volume":"6","author":"Mart\u00edn-Tim\u00f3n I","year":"2015","unstructured":"Mart\u00edn-Tim\u00f3n I, Del Ca\u00f1izo-G\u00f3mez FJ. Mechanisms of hypoglycemia unawareness and implications in diabetic patients. World J Diabetes. 2015, 6:912-26. 10.4239\/wjd.v6.i7.912","journal-title":"World J Diabetes"},{"key":"ref37","doi-asserted-by":"publisher","DOI":"10.2174\/1381612828666220421135523","article-title":"Beta blockers can mask not only hypoglycemia but also hypotension","volume":"28","author":"Koracevic G","year":"2022","unstructured":"Koracevic G, Micic S, Stojanovic M, et al.. Beta blockers can mask not only hypoglycemia but also hypotension. Curr Pharm Des. 2022, 28:1660-8. 10.2174\/1381612828666220421135523","journal-title":"Curr Pharm Des"},{"key":"ref38","doi-asserted-by":"publisher","DOI":"10.1007\/s10877-022-00848-8","article-title":"What is new in hemodynamic monitoring and management?","volume":"36","author":"Flick M","year":"2022","unstructured":"Flick M, Bergholz A, Sierzputowski P, Vistisen ST, Saugel B. What is new in hemodynamic monitoring and management?. J Clin Monit Comput. 2022, 36:305-13. 10.1007\/s10877-022-00848-8","journal-title":"J Clin Monit Comput"},{"key":"ref39","doi-asserted-by":"publisher","DOI":"10.1016\/j.ekir.2021.11.029","article-title":"A novel hypertension management algorithm guided by hemodynamic data","volume":"7","author":"Greco B","year":"2022","unstructured":"Greco B, Chait Y, Nathanson BH, Germain MJ. A novel hypertension management algorithm guided by hemodynamic data. Kidney Int Rep. 2022, 7:330-3. 10.1016\/j.ekir.2021.11.029","journal-title":"Kidney Int Rep"},{"key":"ref40","doi-asserted-by":"publisher","DOI":"10.1016\/j.jcrc.2018.07.017","article-title":"A novel technique to establish hemodynamic monitoring in patients supported with extracorporeal life support systems (ECLS) for cardiopulmonary resuscitation (ECPR)","volume":"47","author":"Lunz D","year":"2018","unstructured":"Lunz D, Philipp A, Birner C. A novel technique to establish hemodynamic monitoring in patients supported with extracorporeal life support systems (ECLS) for cardiopulmonary resuscitation (ECPR). J Crit Care. 2018, 47:219-21. 10.1016\/j.jcrc.2018.07.017","journal-title":"J Crit Care"},{"key":"ref41","unstructured":"Novel tools for hemodynamic monitoring in critically ill patients with shock. (2023). Accessed. May 26, 2024: https:\/\/www.uptodate.com\/contents\/novel-tools-for-hemodynamic-monitoring-in-critically-ill-patients-with-shock."},{"key":"ref42","doi-asserted-by":"publisher","DOI":"10.3390\/jpm11111239","article-title":"Precision medicine in phaeochromocytoma and paraganglioma","volume":"11","author":"Winzeler B","year":"2021","unstructured":"Winzeler B, Challis BG, Casey RT. Precision medicine in phaeochromocytoma and paraganglioma. J Pers Med. 2021, 11:1239. 10.3390\/jpm11111239","journal-title":"J Pers Med"},{"key":"ref43","doi-asserted-by":"publisher","DOI":"10.1210\/endrev\/bnab019","article-title":"Personalized management of pheochromocytoma and paraganglioma","volume":"43","author":"N\u00f6lting S","year":"2022","unstructured":"N\u00f6lting S, Bechmann N, Taieb D, et al.. Personalized management of pheochromocytoma and paraganglioma. Endocr Rev. 2022, 43:199-239. 10.1210\/endrev\/bnab019","journal-title":"Endocr Rev"},{"key":"ref44","doi-asserted-by":"publisher","DOI":"10.1111\/joim.12507","article-title":"Precision medicine in pheochromocytoma and paraganglioma: current and future concepts","volume":"280","author":"Bj\u00f6rklund P","year":"2016","unstructured":"Bj\u00f6rklund P, Pacak K, Crona J. Precision medicine in pheochromocytoma and paraganglioma: current and future concepts. J Intern Med. 2016, 280:559-73. 10.1111\/joim.12507","journal-title":"J Intern Med"}],"container-title":["Cureus"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.cureus.com\/articles\/261764-esmolols-role-in-hemodynamic-management-during-pheochromocytoma-surgery-a-comprehensive-review","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,6,6]],"date-time":"2024-06-06T09:29:01Z","timestamp":1717666141000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.cureus.com\/articles\/261764-esmolols-role-in-hemodynamic-management-during-pheochromocytoma-surgery-a-comprehensive-review"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,6,6]]},"references-count":44,"URL":"https:\/\/doi.org\/10.7759\/cureus.61786","relation":{},"ISSN":["2168-8184"],"issn-type":[{"value":"2168-8184","type":"print"}],"subject":[],"published":{"date-parts":[[2024,6,6]]}}}